News 23.04.2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News 29.09.2020 Leading orthopedic implant manufacturer Symbios invests CHF 50 million in its new factory Symbios Orthopédie is investing more than CHF 50 million at Y-PARC for the construction of its new 12,000 square meter production plant. This inv...
Actualités 12.08.2020 Adiposs, spin-off de l’Université de Genève, obtient CHF 100’000 pour combattre la cachexie cancéreuse La start-up biotechnologique genevoise Adiposs a développé un produit d'imagerie médicale révolutionnaire capable de détecter un syndrome grave a...
News 15.02.2022 ARTORG Center spin-off PeriVision awarded EUR 1.5 million Bernese start-up PeriVision topped the EIT Wild Card 2021 challenge, winning EUR 1.5 million to finalize its first product and prepare its EU and...
News 28.06.2022 A hydrogel for the treatment of metastatic melanoma Researchers from the University of Bern have developed a treatment that activates the body's own defense system against black skin cancer. Compon...
News 05.07.2022 CHF 178 million to further develop life sciences in the canton of Vaud To consolidate the development of life sciences in the canton of Vaud, the State Council has announced an investment of CHF 178.71 million in the...
News 31.05.2022 RetinAI enters a multi-year software license agreement with Novartis Building on their existing relationship, Bern-based RetinAI and pharma giant Novartis have entered a long-term collaboration with a multi-year so...
News 03.05.2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
News 09.06.2022 Digitization and AI applications in medicine at the University of Bern A research team from the University of Bern and the Inselspital is investigating and developing innovative approaches that will enable personaliz...
Aktuell 11.12.2020 Patienten profitieren von innovativem Technologieprojekt Basel Area Business & Innovation, die Agentur für Standortpromotion und Innovationsförderung, spannt mit mehreren Partnern bei einem Technolo...
News 12.01.2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News 03.05.2021 EPFL spin-off ONWARD raises $ 32 million for its spinal cord therapies ONWARD has raised $ 32 million to further develop and commercialize its ARC therapy stimulating the spinal cord to restore movement.
Aktuell 18.08.2020 Switzerland Innovation Park Basel Area eröffnet Standort auf dem Novartis Campus Der Switzerland Innovation Park Basel Area eröffnet seinen neuen Standort auf dem Novartis Campus. Die Betreiberin Basel Area Business & Inno...
Success stories 21.04.2021 Deloitte’s Future of Health Initiative: “We have all of the parts of the value chain here, from R&D to manufacturing to commercialization.“ Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to ...
News 03.11.2021 Opening of the NeuroTec research facility in Bern After almost two years of development, the NeuroTec research facility was launched. NeuroTec explores the use of modern medical technology to imp...